Meridian to market E coli rapid test in US:
This article was originally published in Clinica
Meridian Diagnostics will market its ImmunocardStat! E coli 0157 Plus rapid test in the US. The test determines whether E Coli is the cause of gastroenteric-related disease in ten minutes. The Cincinnati, Ohio-based company claims prompt diagnosis of the infection can reduce healthcare costs, by preventing acute renal failure and haemolytic uraemic syndrome, brought on by the toxins generated by the bacterium.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.